Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Source Reference: Irving SA, et al "Infant respiratory syncytial virus immunization coverage in the Vaccine Safety Datalink: 2023-2024" Pediatrics 2025; DOI: 10.1542/peds.2024-070240.

Parental trust in clinicians drove RSV vaccine uptake, while confusion and limited access to reliable information hindered ...

SAN DIEGO — In 2024, administration of the four FDA-approved RSV vaccinations was low, ranging from 0.27% to 0.58%, according to a poster presented here.These data were presented at the 2025 ...

Geometric mean fold rise in titers from before to 1 month postvaccination for RSV-A and RSV-B were 11.6 vs 1.1 and 12.7 vs 1.1 in the RSVpreF vs placebo group, respectively.

2 Schmoele-Thoma B, Zareba AM, Jiang Q, et al. Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. N Engl J Med. 2022 Jun 23;386 (25):2377-2386. doi: 10.1056/NEJMoa2116154.

Last June, ACIP unanimously recommended that all adults ages ≥75 years and adults ages 60 to 74 years who are at increased risk of severe RSV disease receive a single dose of RSV vaccine; the ...